Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Molly O. Regelmann"'
Autor:
Heba Al-Rayess, Amit Lahoti, Leslie Long Simpson, Elise Palzer, Paul Thornton, Ryan Heksch, Manmohan Kamboj, Takara Stanley, Molly O. Regelmann, Anshu Gupta, Vandana Raman, Shilpa Mehta, Mitchell E. Geffner, Kyriakie Sarafoglou
Publikováno v:
Children, Vol 10, Iss 12, p 1871 (2023)
A Pediatric Endocrine Society (PES) Drugs and Therapeutics Committee workgroup sought to determine the prescribing practices of pediatric endocrinologists when treating children
Externí odkaz:
https://doaj.org/article/17a03bf7c1cb49a689e2c2da95696c84
Autor:
Isha Kachwala, Molly O. Regelmann
Publikováno v:
International Journal of Neonatal Screening, Vol 8, Iss 1, p 18 (2022)
Adrenoleukodystrophy (ALD) is a peroxisomal disorder affecting the nervous system, adrenal cortical function, and testicular function. Newborn screening for ALD has the potential to identify patients at high risk for life-threatening adrenal crisis a
Externí odkaz:
https://doaj.org/article/f9d9177728de4c838c554e6a6f07ea8b
Autor:
Lauren Iacono, Molly O. Regelmann
Publikováno v:
JAMA network open. 5(5)
Autor:
Liane Eng, Molly O. Regelmann
Publikováno v:
Current Opinion in Endocrinology, Diabetes & Obesity. 27:47-55
Adrenoleukodystrophy (ALD) is a peroxisomal disorder with varying clinical presentations, including adrenal insufficiency, neurologic disease, and testicular dysfunction. The present review is intended to describe the current knowledge of the pathoph
Autor:
Isha Kachwala, Molly O. Regelmann
Publikováno v:
International journal of neonatal screening. 8(1)
Adrenoleukodystrophy (ALD) is a peroxisomal disorder affecting the nervous system, adrenal cortical function, and testicular function. Newborn screening for ALD has the potential to identify patients at high risk for life-threatening adrenal crisis a
Autor:
Molly O, Regelmann, Bradley C, Clark
Publikováno v:
The Journal of pediatrics. 237
Autor:
Liane Eng, Molly O. Regelmann
Publikováno v:
The Journal of Pediatrics. 211:211-214
The lifetime risk for adrenal insufficiency in male children with adrenoleukodystrophy (ALD) is estimated at 80%-86%. Prior to newborn screening, male children with ALD were identified by family history or after symptom development. These young patie
Autor:
Rachel A. Annunziato, Mabel Yau, Elizabeth Chacko, Molly O. Regelmann, Dennis J. Chia, Robert Rapaport, Elizabeth Wallach
Publikováno v:
Hormone Research in Paediatrics. 92:36-44
Background/Aims: Studies are lacking regarding the timing of peak growth hormone (PGH) response. We aim to elucidate the timing of PGH response to arginine and levodopa (A-LD) and evaluate the influence of body mass index (BMI) and other metabolic pa
Autor:
Helena Yan, Joanne Kurtzberg, Troy C. Lund, Ann B. Moser, Gerald V. Raymond, Ali Fatemi, Florian Eichler, Keith Van Haren, Gustavo Maegawa, Adeline Vanderver, Bela R. Turk, Molly O. Regelmann, Carrie Price, Michelle Demetres, Stephan Kemp, Paul J. Orchard, Elisa Seeger, Eric J. Mallack, Laura Adang, Maura R.Z. Ruzhnikov, Joseph J. Orsini, Kim Hollandsworth, Catherine Becker
Publikováno v:
J Inherit Metab Dis
Journal of inherited metabolic disease, 44(3), 728-739. Springer Netherlands
Journal of inherited metabolic disease, 44(3), 728-739. Springer Netherlands
Background Among boys with X-Linked adrenoleukodystrophy, a subset will develop childhood cerebral adrenoleukodystrophy (CCALD). CCALD is typically lethal without hematopoietic stem cell transplant before or soon after symptom onset. We sought to est
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e378d7e0089bc5e5ce97cff83eebba43
https://europepmc.org/articles/PMC8113077/
https://europepmc.org/articles/PMC8113077/
Autor:
Sowmya Krishnan, Rushika Conroy, Kristal Matlock, Amit Lahoti, Ryan Heksch, Evgenia Gourgari, Manmohan K. Kamboj, Ines Guttmann-Bauman, Molly O. Regelmann, Anshu Gupta
Publikováno v:
Hormone Research in Pædiatrics
Background: Pediatric endocrine practices had to rapidly transition to telemedicine care at the onset of the novel coronavirus disease 2019 (COVID-19) pandemic. For many, it was an abrupt introduction to providing virtual healthcare, with concerns re